Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review
Stefano Paolo Beltrametti,1 Aurora Ianniello,2 Clara Ricci3 1Department of Rheumatology, S. Andrea Hospital, Vercelli, 2Rheumatology Outpatient Clinic, Novara, 3Primula Multimedia S.p.A, Pisa, Italy Abstract: To date, rheumatoid arthritis (RA) remains a debilitating, life-threatening disease. One ma...
Saved in:
Main Authors: | Beltrametti SP (Author), Ianniello A (Author), Ricci C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
by: Krasselt M, et al.
Published: (2016) -
Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability
by: Bandinelli F, et al.
Published: (2016) -
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values
by: Dunlop W, et al.
Published: (2013) -
New Insights Into Cancer Chronotherapies
by: Jingxuan Zhou, et al.
Published: (2021) -
Low-Dose Prednisone Treatment for IVIG-Resistant Kawasaki Disease with Severe Arthritis and Joint Effusion in Two 3-Year-Old Children
by: Lingling Fan, et al.
Published: (2021)